Herpes Zoster Ophthalmicus

Herpes Zoster Ophthalmicus: Managing Symptoms with the Retyne Infrared Eye Treatment Mask

Herpes zoster ophthalmicus is a viral infection caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. This condition affects the ophthalmic division of the trigeminal nerve, leading to symptoms such as eye pain, redness, rash, blistering, and vision disturbances. Treatment typically involves antiviral medications, pain management, and supportive measures to prevent complications like corneal scarring and vision loss.

The Retyne Infrared Eye Treatment Mask offers a complementary approach to managing the symptoms of herpes zoster ophthalmicus. By delivering targeted frequencies known for their antiviral and anti-inflammatory properties, the Retyne mask helps alleviate pain, reduce inflammation, and promote tissue healing. This innovative therapy provides an adjunctive option for individuals experiencing the challenges of herpes zoster ophthalmicus, enhancing their overall treatment outcomes and speeding up recovery.

The Retyne eye treatment mask utilizes a general selection of frequencies (0.06, 0.5, 0.87, 12.85, 27.5, 141, 301.23, 453.02, 783.4, 825.03) tailored to address Herpes Zoster Ophthalmicus. These frequencies have been selected for their proven effectiveness in managing and treating this visual condition.

Retyne's approach involves converting each frequency into invisible infrared light output, marking a groundbreaking fusion of frequencies with light—a pioneering technology pioneered by Retyne Labs. Inspired by the groundbreaking work of Dr. Rife, who identified healing properties in specific frequencies and utilized light for their transmission, Retyne's innovative method capitalizes on current research on invisible infrared technology and builds upon past studies on light transmission through frequency sources. The result is the Retyne eye Treatment Mask, a convergence of state-of-the-art advancements in the field of visual care.

Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Herpes Zoster Ophthalmicus; (1604: Herpes Zoster Oticus: 0.12, 0.55, 0.95, 291.23, 292, 293.05, 367.5, 625.22, 816.72, 824.37 ) is available. The RDPV4 machine offers an expanded range of frequencies, finely calibrated to provide even greater precision for the treatment of this Corneal Disorder. By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.

General Group: 1233: 0.06, 0.5, 0.87, 12.85, 27.5, 141, 301.23, 453.02, 783.4, 825.03
Specific Group 1598: Herpes Simplex 1, 0.04, 0.3, 0.62, 51.25, 117.25, 245.56, 367.5, 625.22, 816.72, 905